Kylo-11 / Lp(a) · Live content package

Create a 5 minute video, make sure is at least 5 minutes. inspirational, epic video with cinematic music, Modern with an intro that’s a Hook about what the video is going to be talking about with B roll. In the first 2 seconds start by describing what the video is going to be about with a hook. B roll must be Nat Geo, imax level quality’s That is a visual representation of the subject, at a glance, zooming in into a molecular level. Make sure th animations are scientifically correct animations or B roll of the subject.

FRAMING (CRITICAL): This is about a NEW WAY OF DOING HEALTHCARE — proactive, genetics-aware, clinician-led prevention and risk detection. NEVER use the word "longevity". Never say longevity, longevity medicine, or anti-aging. Use language like: proactive care, knowing your risks early, expanding human vitality through better clinical practice, a new standard of care.

SUBJECT: Kylo-11 (spell exactly Kylo-11, never KYLLO), Lancet 2026 Phase 1 first-in-human long-duration siRNA lowering lipoprotein(a)/Lp(a). Ashish Sarraju, Cleveland Clinic. One SC injection cut Lp(a) ~53–97% at 48 weeks; highest doses ~95–97% for nearly a year. Lp(a) ~80–90% genetic; diet/exercise barely move it; under-tested. Phase 1 safety + biomarker only — NOT proven CV outcome benefit. Phase 2 underway. CTA: ask once for an Lp(a) blood test.

Then introduce Myself as , Hi! if we have not met yet, I am the AI for Dr. zuleta. While he is working clinically and with teams to improve health, i am here sharing his messages. Mention Dr zuleta is the founder of Thrivemed, a company that works to expand human vitality. He writes every script and him and his team read every comment.

Then the subject — inspiring potential AND weaknesses — analogies + animations, the study, inspirational outro.
Analogies: Lp(a) as genetically sticky cholesterol-like particle; Kylo-11 siRNA as mute button for the liver’s Lp(a) factory (apo(a)).

Speech ~1.2x engaging. Lots of B-roll, camera/zoom changes on digital avatar. Don’t say his name more than once. Particle-design twin zoom whole→molecular. When sharing research zoom into TITLE only with highlight animations and show images of the paper. Explain so anyone understands. End with "stay vital" EXACTLY ONCE at the very end — never earlier.

Cinematic effects throughout. B-roll like high-end scientific documentary. Music: Epic cinematic hybrid orchestral 105-115 BPM — massive drum + brass braam open, driving staccato strings + sub-bass, deep brass swells, soaring strings, propulsive bed, crescendo to triumphant climax. Polished and grand. Vary musical sections so it does not feel looped or repetitive.

No invented clinical claims. No longevity wording.

Create a ~3 minute YouTube video (target 2:45–3:15).

Hook in first 2 seconds with Nat Geo/IMAX B-roll of Lp(a) zooming molecular.
Intro once: Hi! if we have not met yet, I am the AI for Dr. zuleta. While he is working clinically and with teams to improve health, i am here sharing his messages. ThriveMed expands human vitality. He writes every script; he and his team read every comment. Name at most once.

FRAMING: NEW WAY OF DOING HEALTHCARE / proactive clinical risk care. NEVER say longevity.

SUBJECT: Kylo-11 (never KYLLO) — Lancet Aug 2026 Phase 1 siRNA for Lp(a). One shot ~53–97% drop at 48 weeks; high doses ~95–97% ~1 year. Sarraju/Cleveland Clinic. Genetic risk; ask for the lab once. Potential + weaknesses: exciting durable lowering; Phase 1 only — not outcome data; Phase 2 underway.

Speech ~1.2x. Lots of B-roll, avatar zooms, particle twin. Paper TITLE zoom only + paper imagery. Analogies + correct molecular animations.

MUSIC (CRITICAL): Epic cinematic hybrid orchestral 105-115 BPM BUT with clear evolving sections — distinct intro hit, mid verse bed, bridge swell, final climax. DO NOT use a short looping/repetitive bed. Music must feel varied and film-scored, not a repeating loop.

OUTRO: Say "stay vital" EXACTLY ONE TIME at the very end. Do not say stay vital earlier. Do not repeat it.

No invented claims. No longevity.

Create a short vertical Reel for Instagram Reels / TikTok / YouTube Shorts — portrait 9:16, about 45–60 seconds. MAXIMUM cinematic production value: IMAX scientific documentary look, volumetric light, elegant camera moves, molecular zooms that feel premium film — not stock or flat.

Hook in first 2 seconds: most people never get tested for Lp(a); Lancet 2026 one-shot Kylo-11 dropped levels ~95–97% for nearly a year in Phase 1.

Navy scrubs digital twin avatar. Speech ~1.2x. Spell Kylo-11 never KYLLO. NEVER say longevity — frame as proactive healthcare / knowing your inherited risk.

Brief AI-for-Dr-Zuleta only if it fits without killing pace. ThriveMed once max. Name at most once.

Simple explain: Lp(a) inherited; diet won’t fix; siRNA mute button for liver Lp(a) factory; Phase 1 only — not proven to prevent heart attacks yet. CTA: ask for Lp(a) once.

Music: short epic hybrid orchestral sting with progression (not a loop). End with stay vital ONCE.

High energy cuts, scientifically correct animations, cinematic grade color and depth.

Write a ready-to-paste LinkedIn post as Andres Zuleta MD MMM (Doctor Zuleta / ThriveMed) on Kylo-11, matching his liquid-biopsy LinkedIn style.

STYLE
- Short punchy paragraphs (1 to 3 sentences), mobile white space
- Order: hook → problem → The Lancet 2026 finding → GROUNDBREAKING “For the first time…” beat (specific) → mechanism → FUTURE STAKES “This matters for the future because it could mean…” beat → takeaways → honest Phase 1 caveats → memorable closer → CTA → hashtags
- CTA exactly: “Full study linked in the comments.”
- NEVER use the word longevity (or longevity medicine / anti-aging). Closer = proactive healthcare / new way of doing care / genetics-aware prevention.
- Spell Kylo-11 correctly (never KYLLO)
- No em dashes or en dashes. Prefer commas, periods, colons, or “to” for ranges.
- Attach note: ONE real study figure only (study-fig1-lpa-over-time.png)
- Groundbreaking beat must be concrete (e.g. first-in-human; first time a single gene-silencing dose held ~95 to 97% Lp(a) drop for nearly a year). Do not invent firsts the paper does not support.
- Future-stakes beat must stay conditional (could mean / if later outcome trials confirm). Never claim heart-attack prevention from Phase 1 alone.

FACTS
- Lancet Phase 1 Kylo-11 long-duration siRNA for Lp(a); Sarraju / Cleveland Clinic
- One SC injection; about 53 to 97% Lp(a) drop at 48 weeks; high doses about 95 to 97% nearly a year
- Lp(a) about 80 to 90% genetic; under-tested; no approved Lp(a)-specific drug yet
- Phase 1 = safety + biomarker only, NOT CV outcome proof; Phase 2 underway
- DOI https://doi.org/10.1016/S0140-6736(26)01484-4

Also output a pin-comment with the DOI and Cleveland Clinic release link.

Write an X/Twitter post as Doctor Zuleta / ThriveMed on Kylo-11 in Andres’s LinkedIn-derived social style, compressed for X.

DELIVER
A) Preferred: 3–5 tweet thread (hook → journal/result → mechanism → caveats → closer + CTA)
B) Alternate: one post under ~280 characters (link/DOI can sit in reply)

RULES
- Short punchy lines; no longevity wording; spell Kylo-11 never KYLLO
- Phase 1 honesty: biomarker/safety only — no heart-attack prevention claims
- CTA: Full study linked in the comments
- Hashtags on final tweet
- Image note: attach ONE real study figure (study-fig1.png) on tweet 1

FACTS
Lancet 2026 Phase 1 Kylo-11 siRNA Lp(a); Sarraju/Cleveland Clinic; one injection; ~53–97% at 48 weeks; high doses ~95–97% ~1 year; Lp(a) 80–90% genetic; under-tested; Phase 2 underway; DOI https://doi.org/10.1016/S0140-6736(26)01484-4

# Reusable social prompt — Doctor Zuleta LinkedIn / X

Distilled from Andres’s liquid-biopsy LinkedIn example (Sep 2026) and applied to Kylo-11. Paste this into Cursor / ChatGPT with a new paper’s PDF, DOI, or notes.

---

## PROMPT (copy everything below)

```
You are writing as Andres Zuleta MD MMM (Doctor Zuleta / ThriveMed) for LinkedIn and X.

VOICE & RULES
- Short punchy paragraphs (1–3 sentences). Lots of white space for mobile.
- Professional, clear, human — not hype, not academic fog.
- NEVER use the word “longevity” (or longevity medicine / anti-aging). Frame as: proactive healthcare, genetics-aware risk detection, a new way of doing care / new standard of care, expanding human vitality through better clinical practice.
- Spell drug/device names exactly as in the paper. Never invent spellings.
- No invented clinical claims. Separate “what the study measured” from “what it proves.”
- CTA line exactly: “Full study linked in the comments.”
- End with 4–6 relevant hashtags.
- Instruct to attach ONE real study figure (not stock art) as the visual.
- No em dashes or en dashes in LinkedIn post body. Prefer commas, periods, colons, or “to” for ranges.
- Must include a specific “For the first time…” groundbreaking beat and a “This matters for the future because it could mean…” beat. Keep outcome hopes conditional. Never claim heart-attack prevention from Phase 1 alone.

STRUCTURE (follow this order)
STRUCTURE (follow this order)
1) HOOK: startling stat or systemic problem (what’s broken / ignored).
2) PROBLEM: why it matters in plain language (who doesn’t know, what’s missing from usual care).
3) JOURNAL FINDING: name the high-authority journal + year + one crisp what-happened sentence (who / what intervention / key number).
4) GROUNDBREAKING (“first time…”): be specific about what is first or newly possible in humans. Name the concrete first (e.g. first-in-human, first time a single dose held X% for nearly a year). Do not invent “firsts” the paper does not support.
5) MECHANISM: plain-language how it works (one strong analogy max).
6) FUTURE STAKES (“this matters for the future because it could mean…”): one clear paragraph on why the finding matters if later evidence holds, while staying honest that outcomes are not proven yet.
7) BENEFITS / TAKEAWAYS: specific numbers and practical meaning; short fragment sentences OK for rhythm.
8) CAVEATS: honest limits (phase, sample, what is NOT proven). “Is it perfect? No…” energy is good.
9) CLOSER: memorable paradigm line (reactive to proactive; listening to biology; new way of doing care). NOT longevity.
10) CTA: “Full study linked in the comments.”
11) HASHTAGS
12) IMAGE NOTE: attach one actual figure from the study.

ALSO PRODUCE
A) LinkedIn post (full length, ready to paste)
B) X version: either a 3–5 tweet thread OR one tight post under the character limit
C) Pin-comment text with DOI / open-access link

INPUT PAPER
Title:
Journal / date:
Authors / institution:
DOI:
Key numbers (dose, %, duration, N):
Mechanism (1 sentence):
What we CAN claim:
What we MUST NOT claim:
Audience CTA (lab / behavior / follow science):
Preferred hashtags (optional):
```

---

## Structure cheat-sheet (from liquid-biopsy example)

| Beat | Liquid-biopsy example | Kylo-11 application |
|---|---|---|
| Hook | “60% of cancers diagnosed stage 3–4…” | Most people with high Lp(a) never tested |
| Journal | Nature Medicine landmark review | The Lancet Phase 1 2026 |
| Mechanism | ctDNA fragments in blood | siRNA mute button on liver Lp(a) factory |
| Caveats | False positives; pathways undefined | Phase 1; not outcome data; not approved |
| Closer | “The blood already knows…” | Proactive / genetics-aware care — new way of doing healthcare |
| CTA | Full study linked in the comments | Same |
| Visual | One real study figure | One real study figure |

---

## Hard bans
- Word: longevity (any form)
- Outcome claims without outcome data
- “Approved / available / cures”
- Wrong drug spelling (e.g. KYLLO instead of Kylo-11)
- Multiple images or stock hero art instead of one study figure